ArticleDiabetology & metabolic syndrome2023

Therapeutic effects on the development of heart failure with preserved ejection fraction by the sodium-glucose cotransporter 2 inhibitor dapagliflozin in type 2 diabetes.

Bin Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.